Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-22-001068
Filing Date
2022-04-04
Accepted
2022-04-04 17:10:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da113392002_04042022.htm SC 13D/A 71319
  Complete submission text file 0000921895-22-001068.txt   73023
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Subject) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-51477 | Film No.: 22803626
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114
Business Address 2261 MARKET STREET #4307 SAN FRANCISCO CA 94114 4158571965
Funicular Fund, LP (Filed by) CIK: 0001752618 (see all company filings)

EIN.: 831460042 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A